LICENSE AND COLLABORATION AGREEMENTS (Tables)

9 Months Ended

Sep. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Certain Activity Related to Revenue with Supply Agreement

The following table summarizes certain Roche activity for each of the periods indicated:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2026			2025			2026			2025
	(in thousands)
Contract manufacturing revenue	$	50,100		$	18,705		$	135,604		$	63,107
Royalty revenue		7,488			10,608			19,834			22,007
Roche product cost of sales		(47,581	)		(17,527	)		(145,437	)		(51,488	)